Van Heron Labs, founded in February 2020 by Dr. Rebecca Vaught, Dr. Alec Santiago and Nithin Parsan at the Texas Medical Center in Houston, applies genomics, bioinformatics, AI and nanotechnology to improve how cells are cultured and harnessed. Its automated flagship platform uses AI and bioinformatics to determine optimal cellular fuel, including a full range of macro- and micronutrients based on genetic data, optimising processes at a molecular level. The company says its technologies improve cell health, proliferation and productivity, often by fold-changes, making cell-based industries more scalable and practical. Van Heron Labs works across multiple industries, with applications in cell therapy, cultivated meat, biomaterials, biotherapeutics, precision medicine, food and synthetic biology. The team generated supporting data and completed two successful commercial pilots for a COVID-19 vaccine manufacturer within two months of founding, and has since continued improving its flagship platform and developing new products and services. The company raised a seed round to advance its technologies and bring new offerings to customers.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Mar 2024